The SYNERGY trial: Study design and rationale
- 1 June 2002
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 143 (6) , 952-960
- https://doi.org/10.1067/mhj.2002.122120
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Randomized, Placebo-Controlled Trial of Titrated Intravenous Lamifiban for Acute Coronary SyndromesCirculation, 2002
- Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor TirofibanNew England Journal of Medicine, 2001
- Shifting the open-artery hypothesis downstream: the quest for optimal reperfusionJournal of the American College of Cardiology, 2000
- ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)Published by Elsevier ,2000
- Assessment of the Treatment Effect of Enoxaparin for Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre studyThe Lancet, 1999
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992